AzTrials
AzTrials

Type 2 DiabetesNCT05687968

Innovative Approaches in Diabetes Care

A study testing Real-Time Personalized Dietary Feedback (via AI and Nutritionist) and conventional nutrition education by dietitian in people with Type 2 Diabetes and AI-supported Real-time Dietary Feedback, run by Taipei Medical University at 1 site in Taiwan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

In Taiwan, an estimated 2.3 million individuals have diabetes, with a 44% increase observed among young adults and adolescents. Poor dietary habits and sedentary lifestyles are major risk factors for type 2 diabetes. Read more about this study

Who is it for?
Ages 20 years and older
What is being tested?
Real-Time Personalized Dietary Feedback (via AI and Nutritionist) and conventional nutrition education by dietitian
Could I receive a placebo?
No, everyone receives an active treatment
How many people
39 participants
Where
1 siteTaiwan
Study dates
19 Oct 2022to 1 Oct 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 20 years old or older
  • Pre-diabetes or diabetes
  • Taiwan nationality or fluent in Mandarin or Taiwanese
  • Not pregnant or breastfeeding
  • Capable (or assisted by a caregiver) of using a smartphone to photograph and record meals

Who cannot join

  • Eating disorders
  • Undergoing treatment for severe illnesses that could affect normal dietary intake (e.g., cancer)
  • Unable to use a smartphone to take photos and record food intake.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Taiwan1 site, 1 recruiting
  • Jung-Su Chang

    Taipei, 110

    Jung-Su Chang, PhD, 886-66382736 ext. 6564, susanchang@tmu.edu.tw

    Recruiting

Other trials in Taiwan

About this study

In Taiwan, an estimated 2.3 million individuals have diabetes, with a 44% increase observed among young adults and adolescents. Poor dietary habits and sedentary lifestyles are major risk factors for type 2 diabetes. The widespread use of smartphones has facilitated the development of digital health technologies, including digital food photography and artificial intelligence (AI), which show promise for personalized nutrition care and health promotion. While such technologies have demonstrated short-term success in diabetes management, their long-term effectiveness remains uncertain.

This study aims to evaluate the effectiveness of a digital eHealth care intervention for individuals with diabetes. Participants will be recruited from the Diabetes Shared Care Network and community care centers in Taiwan and followed for 12 months. Eligible participants will be randomly assigned by computer to either a control or an eHealth care group.

Read more
  • eHealth Group: Receives a 10-minute digital nutrition education session using the lab-developed "3D/AR MetaFood food portion education platform" (https://sketchfab.com/susanlab108/collections) and is required to submit weekly dietary records through food images using the "Formosa FoodAPP." Participants will receive immediate dietary feedback from nutritionists, followed by AI-generated personalized feedback on the glycemic index (GI) and glycemic load (GL) of their meals. They will also be provided with educational videos on healthy eating, physical activity, and selecting low-GI/GL foods.

Anthropometric measurements and baseline questionnaires will be collected at enrollment. Blood biochemistry, including HbA1c, will be measured at baseline, and at 3, 6, 9, and 12 months. Collected food image data will be used to train AI systems for real-time dietary feedback and to explore the relationship between nutrient intake and long-term glycemic control.

Read the detailed description

Objective:

This study aims to evaluate the effectiveness of eHealth interventions in the care of patients with diabetes.

Study Design:

Adult participants with diabetes will be recruited from the Diabetes Shared Care Network and community centers for a 12-month intervention study.

Eligibility Criteria:

Participants must be aged 20 years or older, diagnosed with prediabetes or diabetes, of Taiwanese nationality or fluent in Mandarin or Taiwanese, not pregnant or breastfeeding, and capable (or assisted by a caregiver) of using a smartphone to photograph and record meals. Individuals with diagnosed eating disorders will be excluded.

Intervention Arms

  • eHealth Group: Participants will receive 10 minutes of portion size and nutrition education using the lab-developed "MetaFood: 3D/AR Digital Food Education Platform" (https://sketchfab.com/susanlab108/collections). They are required to submit a food image-based dietary record once per week using the lab-developed "Formosa FoodAPP" (1). Trained nutritionists will assess the dietary images using a lab-developed "Digital Photographic Food Atlas" and provide real-time dietary feedback via a LINE social group.

Additionally, the eHealth group will receive educational materials including videos and digital leaflets on:

  1. How to use the Formosa FoodAPP
  2. Introduction to MyPlate: food classification and portion sizes
  3. The impact of food on blood glucose: understanding glycemic index (GI) and glycemic load (GL)
  4. GI/GL values of commonly consumed Taiwanese foods
  5. Interpretation of blood test reports
  6. Making food choices when dining out
  7. Basics of exercise
  8. Eating during festivals

From the 5th month onward, personalized dietary feedback on the GI/GL values of consumed meals will be provided by lab-developed AI systems, continuing until the end of the study. AI systems for food recognition and the LINE group are managed by lab staff.

Biological Measures:

Fasting blood glucose and lipid profiles will be collected every three months during clinic visits.

Sample Size Justification:

Using G*Power 3.1.9.7, the primary endpoint is the effect of AI-supported dietary feedback on glycemic control in middle-aged and older adults with type 2 diabetes. Based on Lee et al.'s study on the combination of human and AI-supported nutrition app, the estimated mean HbA1c difference is 0.52% (7.52±0.81 vs. 7.00±0.66) at 12 months. Assuming an effect size of 0.70, 80% power, and 5% significance, 33 participants per group are needed. Accounting for a 10-20% attrition rate, a total sample of 36-40 participants will be recruited.

Data Collection:

Baseline sociodemographic and anthropometric data will be collected by state-registered dietitians. Standard biochemical test results, available from Taiwan's National Health Insurance, will be collected every three months. Nutrition knowledge, and perceptions and usage of digital food technologies, will be assessed via an online questionnaire developed from the theoretical framework, literature review, and validated by experts. Weekly dietary records will be logged via the Formosa FoodAPP (1).

Data will include:

  • Demographics: Age, sex, education level, disease history
  • Weekly dietary records
  • Anthropometrics: Height, weight, BMI, waist circumference, grip strength, muscle strength
  • Biochemical data: Fasting glucose, lipid profiles, renal function indicators (clinic-based, insurance-covered tests)

Statistical Analysis:

Data will be analyzed using GraphPad Prism 5 (La Jolla, CA, USA).

  • Normality: Kolmogorov-Smirnov test
  • Continuous variables: Mean ± 95% CI; analyzed via t-tests or ANOVA
  • Categorical variables: Frequencies/percentages; analyzed via Chi-square or Fisher's exact test
  • Correlations: Spearman's coefficient; logistic linear regression
  • Nonparametric comparisons: Kruskal-Wallis test
  • Longitudinal analysis: Generalized Linear Mixed Model (GLMM) for glycemic changes and comorbidity risks
  • Significance threshold: p < 0.05
Being tested
Real-Time Personalized Dietary Feedback (via AI and Nutritionist), conventional nutrition education by dietitian
Keywords
Diabetes Mellitus, AI-supported real-time dietary feedback, M-health
Medical subject headings
Diabetes Mellitus, Type 2, Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Real-Time Personalized Dietary Feedback (via AI and Nutritionist)Behavioural

    • Behavioral: "3D/AR MetaFood" Portion Size and Nutrition Education
    • Behavioral: Nutrition and Physical Activity Educational Videos
  • conventional nutrition education by dietitianBehavioural

    The participants receive conventional health and nutrition education from state registered dietitian.

Study groups in NCT05687968
Study groupRoleWhat they receive
eHealth groupExperimentalParticipants in the eHealth group will receive a multi-component digital health intervention. This includes: 1. Real-time personalized dietary feedback based on weekly food image submissions via the Formosa FoodAPP, delivered initially by trained nutritionists and later by AI. 2. A 10-minute digital food portion size and nutrition education session using the lab-developed "3D/AR MetaFood" platform. 3. Access to educational videos on healthy eating, glycemic index/load, physical activity, and digital food recording.
Receives: Behavioral: Real-Time Personalized Dietary Feedback (via AI and Nutritionist); Behavioral: conventional nutrition education by dietitian

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. HbA1c

    the change of HbA1c

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  2. Fasting glucose

    the change of Fasting glucose

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

Secondary outcomes (23)
  1. Triglyceride (TG)

    the change of Triglyceride (TG)

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  2. Total cholesterol (TC)

    the change of total cholesterol (TC)

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  3. Low-density lipoprotein-cholesterol (LDL-C)

    the change of low-density lipoprotein-cholesterol (LDL-C)

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  4. Triglyceride-glucose (TyG)

    the change of triglyceride-glucose (TyG)

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  5. Estimated Glomerular filtration rate (eGFR)

    the change of estimated Glomerular filtration rate (eGFR)

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  6. Creatinine (CRE)

    the change of creatinine (CRE)

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  7. Dietary Intake (Food portion)

    the change of food portion

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  8. Dietary Intake (Energy)

    the change of Energy

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  9. Dietary Intake (Carbohydrate)

    the change of Carbohydrate

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  10. Dietary Intake (Fiber)

    the change of Fiber

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  11. Dietary Intake (Sugar)

    the change of Sugar

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  12. Dietary Intake (Protein)

    the change of Protein

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  13. Dietary Intake (Fat)

    the change of Fat

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  14. Dietary Intake (Saturated Fat)

    the change of Saturated Fat

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  15. Dietary Intake (Cholesterol)

    the change of Cholesterol

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  16. Dietary Intake (Sodium)

    the change of Sodium

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  17. Dietary Intake (Potassium)

    the change of Potassium

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  18. Dietary Intake (Calcium)

    the change of Calcium

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  19. Dietary Intake (Magnesium)

    the change of Magnesium

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  20. Dietary Intake (Iron)

    the change of Iron

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  21. Dietary Intake (Vitamin C)

    the change of Vitamin C

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  22. Dietary Intake (Dietary GI)

    the change of Dietary GI

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

  23. Dietary Intake (Dietary GL)

    the change of Dietary GL

    Measured: baseline, 3 month, 6 month, 9 month, 12 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2023
  2. Study start19 Oct 2022
  3. Primary completion1 Oct 2025 (estimated)
  4. Study completion1 Oct 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
39 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05687968
Sponsor's protocol ID
N202101052
Status last verified
Jun 2025
First submitted
9 Jan 2023
Last updated
30 Jul 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ho DKN, Chiu WC, Kao JW, Tseng HT, Yao CY, Su HY, Wei PH, Le NQK, Nguyen HT, Chang JS. Mitigating errors in mobile-based dietary assessments: Effects of a data modification process on the validity of an image-assisted food and nutrition app. Nutrition. 2023 Dec;116:112212. doi: 10.1016/j.nut.2023.112212. Epub 2023 Sep 9.

    PubMed 37776838
  • Lee YB, Kim G, Jun JE, Park H, Lee WJ, Hwang YC, Kim JH. An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial. Diabetes Care. 2023 May 1;46(5):959-966. doi: 10.2337/dc22-1929.

    PubMed 36821833

Questions about this trial

What is this clinical trial studying?

A study testing Real-Time Personalized Dietary Feedback (via AI and Nutritionist) and conventional nutrition education by dietitian in people with Type 2 Diabetes and AI-supported Real-time Dietary Feedback, run by Taipei Medical University at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jung-Su Chang, PhD. (886-66382736 ext. 6506, susanchang@tmu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

HbA1c (time frame: baseline, 3 month, 6 month, 9 month, 12 month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05687968, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in